table of content
1 Introduction to Research & Analysis Reports
1.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Overall Market Size
2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size: 2022 VS 2029
2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in Global Market
3.2 Top Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies Ranked by Revenue
3.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Companies
3.4 Top 3 and Top 5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in Global Market
3.6.1 List of Global Tier 1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Markets, 2022 & 2029
4.1.2 CellSearch
4.1.3 Others
4.2 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
4.2.1 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
4.2.2 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
4.2.3 By Type - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2022 & 2029
5.1.2 Breast Cancer Diagnosis and Treatment
5.1.3 Prostate Cancer Diagnosis and Treatment
5.1.4 Colorectal Cancer Diagnosis and Treatment
5.1.5 Lung Cancer Diagnosis and Treatment
5.1.6 Other Cancers Diagnosis and Treatment
5.2 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
5.2.1 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
5.2.2 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
5.2.3 By Application - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2022 & 2029
6.2 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue & Forecasts
6.2.1 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2023
6.2.2 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2024-2029
6.2.3 By Region - Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.3.2 US Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.3.3 Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.3.4 Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.4.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.3 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.4 U.K. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.5 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.6 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.7 Nordic Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.4.8 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.5.2 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.3 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.4 South Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.5 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.5.6 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.6.2 Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.6.3 Argentina Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, 2018-2029
6.7.2 Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.3 Israel Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.4 Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
6.7.5 UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, 2018-2029
7 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies Profiles
7.1 Janssen
7.1.1 Janssen Company Summary
7.1.2 Janssen Business Overview
7.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.1.4 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.1.5 Janssen Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.2.4 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Advanced Cell Diagnostics
7.3.1 Advanced Cell Diagnostics Company Summary
7.3.2 Advanced Cell Diagnostics Business Overview
7.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.3.4 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.3.5 Advanced Cell Diagnostics Key News & Latest Developments
7.4 ApoCell
7.4.1 ApoCell Company Summary
7.4.2 ApoCell Business Overview
7.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.4.4 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.4.5 ApoCell Key News & Latest Developments
7.5 Biofluidica
7.5.1 Biofluidica Company Summary
7.5.2 Biofluidica Business Overview
7.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.5.4 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.5.5 Biofluidica Key News & Latest Developments
7.6 Clearbridge Biomedics
7.6.1 Clearbridge Biomedics Company Summary
7.6.2 Clearbridge Biomedics Business Overview
7.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.6.4 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.6.5 Clearbridge Biomedics Key News & Latest Developments
7.7 CytoTrack
7.7.1 CytoTrack Company Summary
7.7.2 CytoTrack Business Overview
7.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.7.4 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.7.5 CytoTrack Key News & Latest Developments
7.8 Celsee
7.8.1 Celsee Company Summary
7.8.2 Celsee Business Overview
7.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.8.4 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.8.5 Celsee Key News & Latest Developments
7.9 Fluxion
7.9.1 Fluxion Company Summary
7.9.2 Fluxion Business Overview
7.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.9.4 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.9.5 Fluxion Key News & Latest Developments
7.10 Gilupi
7.10.1 Gilupi Company Summary
7.10.2 Gilupi Business Overview
7.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.10.4 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.10.5 Gilupi Key News & Latest Developments
7.11 Cynvenio
7.11.1 Cynvenio Company Summary
7.11.2 Cynvenio Business Overview
7.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.11.4 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.11.5 Cynvenio Key News & Latest Developments
7.12 On-chip
7.12.1 On-chip Company Summary
7.12.2 On-chip Business Overview
7.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.12.4 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.12.5 On-chip Key News & Latest Developments
7.13 YZY Bio
7.13.1 YZY Bio Company Summary
7.13.2 YZY Bio Business Overview
7.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.13.4 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.13.5 YZY Bio Key News & Latest Developments
7.14 BioView
7.14.1 BioView Company Summary
7.14.2 BioView Business Overview
7.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.14.4 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.14.5 BioView Key News & Latest Developments
7.15 Fluidigm
7.15.1 Fluidigm Company Summary
7.15.2 Fluidigm Business Overview
7.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.15.4 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.15.5 Fluidigm Key News & Latest Developments
7.16 Ikonisys
7.16.1 Ikonisys Company Summary
7.16.2 Ikonisys Business Overview
7.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.16.4 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.16.5 Ikonisys Key News & Latest Developments
7.17 AdnaGen
7.17.1 AdnaGen Company Summary
7.17.2 AdnaGen Business Overview
7.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.17.4 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.17.5 AdnaGen Key News & Latest Developments
7.18 IVDiagnostics
7.18.1 IVDiagnostics Company Summary
7.18.2 IVDiagnostics Business Overview
7.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.18.4 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.18.5 IVDiagnostics Key News & Latest Developments
7.19 Miltenyi Biotec
7.19.1 Miltenyi Biotec Company Summary
7.19.2 Miltenyi Biotec Business Overview
7.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.19.4 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.19.5 Miltenyi Biotec Key News & Latest Developments
7.20 ScreenCell
7.20.1 ScreenCell Company Summary
7.20.2 ScreenCell Business Overview
7.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.20.4 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.20.5 ScreenCell Key News & Latest Developments
7.21 Silicon Biosystems
7.21.1 Silicon Biosystems Company Summary
7.21.2 Silicon Biosystems Business Overview
7.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Product Offerings
7.21.4 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in Global Market (2018-2023)
7.21.5 Silicon Biosystems Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
